Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 18/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 16/20 | 0.57 |
| ▸ | HPGD | P15428 | 12/20 | 0.57 |
| ▸ | TSHR | P16473 | 9/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 8/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.57 |
| ▸ | USP2 | O75604 | 4/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11947809 | 0.91 | HSD17B10 (0.64) | HSD17B10ALDH1A1HPGDTSHRCYP2D6 | |
| SCHEMBL13168323 | 0.88 | HSD17B10 (0.53) | HSD17B10ALDH1A1HPGDTSHRCYP2D6 | |
| SCHEMBL17516289 | 0.83 | ALDH1A1 (0.58) | HSD17B10ALDH1A1HPGDTSHRCYP2D6 | |
| SCHEMBL11947825 | 0.82 | CYP3A4 (0.53) | HSD17B10ALDH1A1HPGDTSHRCYP2D6 | |
| SCHEMBL14996524 | 0.81 | HSD17B10 (0.61) | HSD17B10ALDH1A1HPGDTSHRCYP2D6 | |
| SCHEMBL136881 | 0.80 | PLD1 (0.56) | HSD17B10ALDH1A1SMN1; SMN2 | |
| SCHEMBL2629501 | 0.77 | USP2 (0.51) | HSD17B10ALDH1A1HPGDTSHRCYP2D6 | |
| SCHEMBL14996516 | 0.77 | HSD17B10 (0.69) | HSD17B10ALDH1A1HPGDTSHRCYP2D6 | |
| SCHEMBL13168160 | 0.77 | HSD17B10 (0.57) | HSD17B10ALDH1A1HPGDTSHRCYP2D6 | |
| SCHEMBL13131034 | 0.76 | MAPT (0.48) | ALDH1A1HPGDCYP2C19CYP2C9SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-8232288-B2 | Substituted benzimidazoles, benzothiazoles and benzoxazoles | GRUENENTHAL GMBH (DE) | 2012-07-31 | — | — | US | disclosed |
| US-8232288-B2 | Substituted benzimidazoles, benzothiazoles and benzoxazoles | GRUENENTHAL GMBH (DE) | 2012-07-31 | — | — | US | disclosed |
| US-20110009382-A1 | Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles | GRUENENTHAL GMBH (DE) | 2011-01-13 | — | — | US | disclosed |
| US-20110009382-A1 | Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles | GRUENENTHAL GMBH (DE) | 2011-01-13 | — | — | US | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | BDKRB1, BDKRB2, REN | HSD17B10 4072/4885ALDH1A1 2086/4885HPGD 386/4885 |
| US-20110009382-A1 | Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles | BDKRB1, BDKRB2, BRD1 | HSD17B10 3943/4885ALDH1A1 1533/4885HPGD 1251/4885 |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | BDKRB1, BDKRB2, REN | HSD17B10 4072/4885ALDH1A1 2086/4885HPGD 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.